Verici Dx plc (LON:VRCI – Get Free Report)’s stock price traded down 16% on Tuesday . The stock traded as low as GBX 0.20 and last traded at GBX 0.21. Approximately 720,676 shares changed hands during trading, a decline of 59% from the average session volume of 1,758,664 shares. The stock had previously closed at GBX 0.25.
Verici Dx Trading Down 16.0%
The company has a market cap of £4.80 million, a P/E ratio of -0.23 and a beta of 1.26. The company has a current ratio of 3.94, a quick ratio of 8.49 and a debt-to-equity ratio of 3.03. The business has a 50 day moving average price of GBX 0.32 and a 200-day moving average price of GBX 0.46.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Further Reading
- Five stocks we like better than Verici Dx
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
